Market revenue in 2023 | USD 46.4 million |
Market revenue in 2030 | USD 122.6 million |
Growth rate | 14.9% (CAGR from 2024 to 2030) |
Largest segment | Targeted sequencing & resequencing |
Fastest growing segment | Targeted Sequencing & Resequencing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Targeted Sequencing & Resequencing, Whole Genome Sequencing, Whole Exome Sequencing |
Key market players worldwide | Illumina Inc, Qiagen NV, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Oxford Nanopore Technologies PLC, PierianDx, Genomatix Software, DNAstar, PerkinElmer, Eurofins Scientific SE, BGI Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next generation sequencing market will help companies and investors design strategic landscapes.
Targeted sequencing & resequencing was the largest segment with a revenue share of 74.14% in 2023. Horizon Databook has segmented the Argentina next generation sequencing market based on targeted sequencing & resequencing, whole genome sequencing, whole exome sequencing covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina next generation sequencing market , including forecasts for subscribers. This country databook contains high-level insights into Argentina next generation sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account